Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

CompletedOBSERVATIONAL
Enrollment

245

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 29, 2024

Study Completion Date

August 29, 2024

Conditions
Hematopoietic Stem Cell Mobilization
Trial Locations (2)

60528

German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen, Institute for Transfusion medicine und Immunohematology Frankfurt am Main, Frankfurt am Main

89081

German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen, Institute for Clinical Transfusion medicine and Immunogenetics Ulm (IKT), Ulm

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Hexal AG

INDUSTRY

lead

Sandoz

INDUSTRY

NCT01766934 - Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors | Biotech Hunter | Biotech Hunter